$7,200.00
N/A
View
Genes Included
×
(collagen binding protein 1), 1, 10, 100kDa, 116kDa, 120kD, 120kDa, 2 (liver, 2'-5'-oligoadenylate synthetase 3, 2'-5'-oligoadenylate synthetase 3 (100 kD), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1, 220kDa, 22kD, 22kDa, 26kD (connexin 26), 26kDa, 26kDa (connexin 26), 3, 3 (Aiolos), 3 dioxygenase, 3)-N-acetyl galactosaminide alpha-2, 3)-N-acetylgalactosaminide alpha-2, 3-beta-galactosyl-1, 350/400kDa, 350/400kDa (mitosin), 37kDa, 4, 44kDa, 5-bisphosphate 3-kinase, 5-trisphosphate receptor, 6-sialyltransferase 2, 6-sialyltransferase), 7, 70kD, 9, 9 (large multifunctional protease 2), 90kD, 91kD, 91kDa, 92kDa gelatinase, 92kDa type IV collagenase), AAC1;N-acetyltransferase 1 (arylamine N-acetyltransferase), ABC50;ATP-binding cassette, ABCA8, ABCB2;transporter 1, ABCB3;transporter 2, ABCF1, ACH;achondroplasia, ACS3, ACTB, ACTR3B, ACVR1B, ACVR1C, ACVRL1, ACVRLK1, ACVRLK3;bone morphogenetic protein receptor, ACVRLK4;activin A receptor, AD2;Alzheimer disease 2 (APOE*E4-associated, ADAM12, ADCY9, ADD1, ADM, ADPRT;ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase), ADPRTL1;ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase)-like 1, ADPRTL2;ADP-ribosyltransferase (NAD+; poly(ADP-ribose) polymerase)-like 2, AGR2, AGS, AGT, AGTR1, AGTR1B;angiotensin receptor 1B, AKT3, ALDH1;aldehyde dehydrogenase 1 family, ALDH1A1, ALDOA, AMP-activated, AMPA 3, ANGPT1, ANILLIN, ANLN, ANPRA, ANX31, ANXA9, AOM;collagen, APH1B, APH1B gamma secretase subunit, API4;apoptosis inhibitor 4, APOD, APOE, APY;IgE responsiveness (atopic), AR, AREG, AREGB;schwannoma-derived growth factor, ARID1A, ARNT2, ARP3 actin-related protein 3 homolog B (yeast), ARVD1, ARVD;arrhythmogenic right ventricular dysplasia 1, AS;ankylosing spondylitis, ASPM, ASPN, AT rich interactive domain 1A (SWI-like), ATA, ATAD2, ATC, ATD;ataxia telangiectasia mutated (includes complementation groups A, ATDC, ATM, ATP-binding cassette, ATP10B, ATPase, AURKA, AURKB, AXIN1, AXIN2, B cell CLL/lymphoma 6, B-cell CLL/lymphoma 11A (zinc finger protein), B-cell CLL/lymphoma 2, B3GNT3, BAD, BAG1, BAI1-associated protein 2-like 1, BAI1-associated protein 3, BAIAP2L1, BAIAP3, BAMBI, BAX, BBC3, BBOX1, BBOX;butyrobetaine (gamma), BCAS1, BCEI;breast cancer, BCL1, BCL11A, BCL2, BCL2 associated athanogene, BCL2-associated X protein, BCL2/adenovirus E1B 19kDa interacting protein 3, BCL2A1, BCL2L1, BCL6B, BDNF, BEK, BIRC5, BLM, BLVR, BLVRA, BM600 (100kD), BM600 (125kD)), BM600 (150kD), BMP and activin membrane-bound inhibitor homolog (Xenopus laevis), BMP antagonist 1, BMP2, BMP2A, BMP2B, BMP4, BMP5, BMP6, BMP7, BMP8A, BMPR1A, BMPR1B, BMPR2, BNC2, BNIP3, BNSP, BOR;eyes absent (Drosophila) homolog 1, BORCS7, BPES3, BRCA1, BRCA2, BTG family, BTG family member 2, BTG2, BWCR, BWS;Beckwith-Wiedemann syndrome, BZS, Bloom syndrome, C and D), C-type lectin domain family 14, C-type lectin domain family 14 member A, C-type lectin domain family 5, C-type lectin domain family 5 member A, C10orf32;chromosome 10 open reading frame 32, C10orf3;chromosome 10 open reading frame 3, C13orf3;chromosome 13 open reading frame 3, C14orf102;chromosome 14 open reading frame 102, C14orf27;chromosome 14 open reading frame 27, C14orf60;chromosome 14 open reading frame 60, C1orf11, C1orf4, C20orf129;chromosome 20 open reading frame 129, C20orf82;chromosome 20 open reading frame 82, C21orf43, C21orf45;chromosome 21 open reading frame 46, C21orf46, C4orf18;chromosome 4 open reading frame 18, C5orf38, C6orf29;chromosome 6 open reading frame 29, C7orf1, CA12, CACNA1D, CACNA1H, CACNA2, CACNA2D1, CACNA2D3, CACNG1, CACNG4, CACNG6, CACNL1A2;calcium channel, CACNL2A, CACNLG;calcium channel, CADASIL;Notch (Drosophila) homolog 3, CALML5, CAMK2B, CAMKB;calcium/calmodulin-dependent protein kinase (CaM kinase) II beta, CARD15;caspase recruitment domain family, CAV1, CAV;caveolin 1, CBFA3;runt-related transcription factor 3, CBLC, CBP1, CBP2, CCHL1A2, CCL2, CCL21, CCL3L1, CCL4, CCL5, CCL7, CCL8, CCN1, CCNA, CCNA1, CCNA2, CCNB, CCNB1, CCND1, CCND2, CCNE, CCNE1, CCNE2, CCNL1, CCR1, CCR2, CCR5, CD114;colony stimulating factor 3 receptor (granulocyte), CD163, CD163 antigen, CD19, CD19 antigen, CD1E, CD1E antigen, CD24, CD24 antigen (small cell lung carcinoma cluster 4 antigen), CD27, CD274, CD274 antigen, CD276, CD276 antigen, CD34, CD34 antigen, CD36, CD36 antigen (collagen type I receptor, CD36 molecule (thrombospondin receptor), CD43, CD44, CD68, CD68 antigen, CD71, CD84, CD84 antigen (leukocyte antigen), CD84 molecule, CD8;CD8 antigen, CD8A, CD8B, CD8B1;CD8 antigen, CDC10 (cell division cycle 10, CDC14 (cell division cycle 14, CDC14 cell division cycle 14 homolog A (S. cerevisiae), CDC14 cell division cycle 14 homolog B (S. cerevisiae), CDC14A, CDC14B, CDC18L;CDC6 (cell division cycle 6, CDC20, CDC20 (cell division cycle 20, CDC20 cell division cycle 20 homolog (S. cerevisiae), CDC25;cell division cycle 25C, CDC25A, CDC25B, CDC25C, CDC28 protein kinase 1B, CDC2;cell division cycle 2, CDC6, CDC6 cell division cycle 6 homolog (S. cerevisiae), CDC7, CDC7 cell division cycle 7 (S. cerevisiae), CDC7L1;CDC7 (cell division cycle 7, CDCA1;cell division cycle associated 1, CDCA5, CDCA7L, CDCA8, CDCL1;minichromosome maintenance deficient (S. cerevisiae) 2 (mitotin), CDH1, CDH2, CDH3, CDH5, CDK1, CDK6, CDKN1;cyclin-dependent kinase inhibitor 1A (p21, CDKN1A, CDKN1B, CDKN1C, CDKN2, CDKN2A, CDKN2B, CDKN2C, CDKN2D, CDKN3, CEA;carcinoembryonic antigen-related cell adhesion molecule 5, CEACAM5, CEACAM6, CENPF, CEP55, CEPTRL2, CFD, CFD1, CGD;chronic granulomatous disease, CHAD, CHEK2, CHI3L1, CHIT1, CHK2 checkpoint homolog (S. pombe), CHRNA5, CIP1, CKB, CKBB;creatine kinase, CKMT1;creatine kinase, CKMT1A, CKS1B, CKTSF1B1, CLDN1, CLDN3, CLDN4, CLDN7, CLEC14A, CLEC5A, CLECSF5;C-type (calcium dependent, CLG4B;matrix metalloproteinase 9 (gelatinase B, CMD1, CMD1J;eyes absent (Drosophila) homolog 4, CMK, CMKBR1;chemokine (C-C motif) receptor 1, CMKBR2;chemokine (C-C motif) receptor 2, CMKBR5;chemokine (C-C motif) receptor 5, CMKLR1, CMPD1;campomelic dysplasia, CNTFR, COCA2;mutL (E. coli) homolog 1 (colon cancer, COL11A1, COL27A1, COL2A1, COL4A6, COL6A3, COL7A1, COL9A3, COLEC12, COLL6;collagen, COMP, CPA3, CPETR, CPETR1, CPETR2, CPETRL2, CRAC1;cysteine knot superfamily 1, CREBBP, CRS;blepharophimosis, CRTL1;cartilage linking protein 1, CRYA2;crystallin, CRYAB, CSE;human T-cell leukemia virus (I and II) receptor, CSF3R, CSPB;granzyme B (granzyme 2, CSPG2;chondroitin sulfate proteoglycan 2, CTLA1, CTLA3;granzyme A (granzyme 1, CTSGL2;granzyme H (cathepsin G-like 2, CTSW, CUB domain, CXADR, CXCL10, CXCL12, CXCL13, CXCL5, CXCL8, CXCL9, CXCR6, CXXC5, CXorf36, CYBB, CYP4F3, Cas-Br-M (murine) ecotropic retroviral transforming sequence c, Cas-Br-M (murine) ectropic retroviral transforming sequence c, Cbl proto-oncogene C, Class V, D11S287E, D11S833E, D12S2489E;DNA segment on chromosome 12 (unique) 2489 expressed sequence, D17S136E, D17S1718, D6S204, DCN, DDB2, DDIT1;growth arrest and DNA-damage-inducible, DDPAC, DDR2, DDX39;DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 39, DDX39A, DEAD-box helicase 39A, DEPDC1, DF, DFNA10, DFNA23;sine oculis homeobox (Drosophila) homolog 1, DFNA3;gap junction protein, DFNB1, DFNB39;deafness, DHRS2, DHTR, DKK1, DKK2, DLG7;discs, DLGAP5, DLL1, DLL3, DLL4, DNAJC12, DPD1;transforming growth factor, DPT, DSC2, DSC3, DTX1, DTX3, DTX4, DUSP4, DUSP6, DnaJ (Hsp40) homolog, Dowling-Meara, Dowling-Meara/Kobner/Weber-Cockayne types), Drosophila), E-cadherin (epithelial), E. coli) (S. cerevisiae), E1AF, E2F transcription factor 5, E2F1, E2F5, E3 ubiquitin protein ligase, EBAF;endometrial bleeding associated factor (left-right determination, EBD1, EBDCT, EBR1;epidermolysis bullosa, EBR2, EBR2A;laminin, EBS2;epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types, EBS3, EBS4;keratin 14 (epidermolysis bullosa simplex, ECGF1;endothelial cell growth factor 1 (platelet-derived), ECM2, EDG1;endothelial differentiation, EDM1, EDN1, EDNRB, EFNA3, EFNA5, EGF, EGF-like 2, EGFR, EGLN2, EGLN3, EIF2AK3, EIF3B, EIF3S9;eukaryotic translation initiation factor 3, EIF4E2, EIF4EBP1, EIF4EL3;eukaryotic translation initiation factor 4E-like 3, ELAM1, ELAM;endothelial adhesion molecule 1, ELF3, ELK3, ELOVL2, EMCN, EMILIN3;elastin microfibril interfacer 3, ENO1, ENO1L1, ENPP2, EP300, EPAS1, EPD1;cartilage oligomeric matrix protein (pseudoachondroplasia, EPLG3;ephrin-A3, EPLG7;ephrin-A5, ERBB2, ERBB4, ERBB;epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b) oncogene homolog), EREG, ESPL1, ESR, ESR1, ESX;E74-like factor 3 (ets domain transcription factor, ETS-domain protein (SRF accessory protein 2), ETV4, ETV7, EVI9;ecotropic viral integration site 9, EVR2;exudative vitreoretinopathy 2 (X-linked), EXO1, EYA1, EYA2, EYA4, F3, FACD, FAM124B, FAM198B, FAM214A, FAM83D, FANCD1, FANCD;Fanconi anemia, FANCF, FAP, FBJ murine osteosarcoma viral oncogene homolog, FBN, FBN1, FCER1B, FGF1, FGF10, FGF12, FGF12B, FGF13, FGF18, FGF2, FGF7, FGF9, FGFA;fibroblast growth factor 1 (acidic), FGFB;fibroblast growth factor 2 (basic), FGFR2, FGFR3, FGFR4, FGL2, FHL1, FIGF;c-fos induced growth factor (vascular endothelial growth factor D), FKHL14;forkhead box C2 (MFH-1, FKHL16, FKHL7, FLI1, FLN2;filamin C, FLNC, FLRT3, FLT3, FNBP1, FNDC6;fibronectin type III domain containing 6, FNRB, FOS, FOS like antigen 1, FOSL1, FOXA1, FOXC1, FOXC2, FOXM1, FOXP3, FRAP, FRAP1;FK506 binding protein 12-rapamycin associated protein 1, FRAP2, FREM2, FST, FSTL1, FSTL3, FUT3, FXYD3, FYVE domain containing 9, FZD10, FZD7, FZD8, FZD9, Friend leukemia virus integration 1, G1 to S and G2 to M, G1P2;interferon, G6PD, GABRP, GADD45A, GADD45B, GADD45G, GAMMA-2, GARP;glycoprotein A repetitions predominant, GAS1, GATA-binding protein 3, GATA-binding protein 4, GATA3, GATA4, GAX;mesenchyme homeo box 2 (growth arrest-specific homeo box), GCPS, GDF15, GDF5, GFRP1;nuclear receptor subfamily 4, GGH, GHR, GJB2, GLI-Kruppel family member GLI3, GLI3, GLUR3;glutamate receptor, GLUT, GLUT1, GNG4, GNLY, GP3A;integrin, GPC4, GPR160, GPX3, GRB2, GRB7, GREM1, GRF1, GRIA3, GRIN1, GRIN2A, GSK3B, GTF2D1, GTF2H2, GUD, GUSB, GZMA, GZMB, GZMH, GZMM, H1F2;H1 histone family, H1FV;H1 histone family, H1c, H2BFJ;H2B histone family, H2bb, H2bh, H3/h, H3FK;H3 histone family, HAPLN1, HAS, HAS1, HBB, HBPA1, HDAC1, HDAC10, HDAC11, HDAC2, HDAC5, HDAC6, HDC, HEG homolog 1 (zebrafish), HEG1, HELLS, HEMK1, HES1, HFSP, HGF, HIF1A, HIST1H1C, HIST1H2BH, HIST1H3H, HIST3H2BB, HK2, HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOB, HLA-DP1A, HLA-DP1B, HLA-DPA1, HLA-DPB1, HLA-DQA, HLA-DQA1, HLA-DQB, HLA-DQB1, HLA-DR1B, HLA-DRA, HLA-DRA1, HLA-DRB1, HLA-E, HLA-JY3, HMG-box), HMGA1, HMGIY;high-mobility group (nonhistone chromosomal) protein isoforms I and Y, HMR, HNF1A, HNF3A;hepatocyte nuclear factor 3, HOX11;homeo box 11 (T-cell lymphoma 3-associated breakpoint), HOX1;homeo box A5, HOX1;homeo box A7, HOX1;homeo box A9, HOX1A, HOX1C, HOX1G, HOX2, HOX2G;homeo box B3, HOXA5, HOXA7, HOXA9, HOXB13, HOXB3, HRY;hairy homolog (Drosophila), HSCR, HSCR2, HSPA2, HTLVR, HYRC, HYRC1, Herlitz junctional epidermolysis bullosa)), IBD1, IBSP, ICAM1, ID1, ID2, ID4, IDDM10;insulin-dependent diabetes mellitus 10, IDO, IDO1, IFNB2;interleukin 6 (interferon, IFT140, IGER, IGF1, IGF1R, IKAROS family zinc finger 3 (Aiolos), IKZF3, IL10R;interleukin 10 receptor, IL10RA, IL11RA, IL12RB2, IL13RA1, IL15RB;interleukin 15 receptor, IL1B, IL1R2, IL1RB;interleukin 1 receptor, IL1RN, IL20RA, IL20RB, IL22RA2, IL24, IL2R, IL2RA, IL2RB, IL3RA, IL4R, IL6, IL6R, IL7R, IL8;interleukin 8, INDO;indoleamine-pyrrole 2, INHBA, INHBB, INP10, INT1L1;wingless-type MMTV integration site family member 2, IPEX;immune dysregulation, IRF6, IRID1, IRX1, ISG15, ISM1, ITGA6, ITGAV, ITGB1, ITGB3, ITGB6, ITPR1, JAG1, JAG2, JAGL1;Alagille syndrome, JAK1, JAK1B, JAK2, JAK3, JAM2, JCAD, JUN, JWS;bacteria-expressed kinase, Jackson-Weiss syndrome, K(lysine) acetyltransferase 2B, KAT2B, KCNB1, KDR, KGFR, KIAA0040, KIAA1370;KIAA1370, KIAA1462;KIAA1462, KIF11, KIF14, KIF23, KIF2C, KIFC1, KIP1, KIP2, KIT, KLRK1, KNSL1;kinesin-like 1, KNSL2;kinesin-like 2, KNSL5;kinesin-like 5 (mitotic kinesin-like protein 1), KNSL6;kinesin-like 6 (mitotic centromere-associated kinesin), KNTC2;highly expressed in cancer, KRT14, KRT17, KRT5, KRT6B, KRT7, KRTL1;keratin-like 1 (a type II keratin sequence), Koebner), L type, LAD1, LAG1, LAG2, LAG3, LAMA3, LAMB2T, LAMB3, LAMC2, LAMNA;laminin, LAMNB1;laminin, LAMNB2, LE;fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, LEF1, LEFTY2, LEMD1, LEP, LEPR, LFNG, LIF, LIFR, LINC01112;long intergenic non-protein coding RNA 1112, LINC02381, LIPD, LMP2;proteasome (prosome, LPL, LPS;Van der Woude syndrome, LRP2, LRRC32, LTB, LTB4H;cytochrome P450, LTBP1, Lewis blood group included), MAD2 (mitotic arrest deficient, MAD2L1, MADH1;MAD, MADH3;MAD, MADH4;MAD, MADH5;MAD, MADHIP;MAD, MAF, MAML2, MAP2K4, MAP3K12, MAPK1, MAPK10, MAPK3, MAPK8IP2, MAPT, MAPTL, MARCO, MCDR2, MCKD1;mucin 1, MCM2, MCM2 minichromosome maintenance deficient 2, MCM3, MCM3 minichromosome maintenance deficient 3 (S. cerevisiae), MCPH5;microcephaly, MDF2;integrin, MDM2, MDM2 proto-oncogene, MDU2, MDU3;CD44 antigen (homing function and Indian blood group system), MECL1;proteasome (prosome, MED1, MELK, MEOX2, MET, MFNG, MFS1, MFS2;transforming growth factor, MHAM, MHS3, MIA, MIC4, MIG;monokine induced by gamma interferon, MIP224;proteasome (prosome, MIS18 kinetochore protein homolog A (S. pombe), MIS18A, MKI67, MLH1, MLLT3, MLM;cyclin-dependent kinase inhibitor 2A (melanoma, MLPH, MME, MMP11, MMP14, MMP3, MMP7, MMP9, MMRN2, MNGIE, MODY3, MPB1;enolase 1, MPSL1;matrix metalloproteinase 7 (matrilysin, MRE11, MRE11 homolog A, MRE11A;MRE11 meiotic recombination 11 homolog A (S. cerevisiae), MRPL19, MRX58;transmembrane 4 superfamily member 2, MS4A2, MSK12, MSK8, MSR1, MT1, MT1G, MTH1;nudix (nucleoside diphosphate linked moiety X)-type motif 1, MTOR, MUC1, MUS81, MUS81 endonuclease homolog (S. cerevisiae), MUS81 endonuclease homolog (yeast), MXS1, MYBL2, MYC, MYCN, MYCT1, MYD118;growth arrest and DNA-damage-inducible, Mdm2, Mdm2 p53 binding protein homolog (mouse), N-cadherin (neuronal), N-methyl D-aspartate 1, N-methyl D-aspartate 2A, NASP, NAT1, NBCCS, NCA;carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen), NCAD;cadherin 2, NCAM1, NCAPH2, NDC80, NDC80 kinetochore complex component, NDC80 kinetochore complex component homolog (S. cerevisiae), NDP, NEIL1, NEIL3, NEO1, NETO2, NFATC1, NFKBIZ, NGFR, NGL;v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog), NKG7, NMDAR1;N-methyl-D-aspartate receptor subunit NR1, NMDAR2A;glutamate receptor, NMYC;v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog, NOD2, NOTCH1, NOTCH2, NOTCH3, NPEPPS, NPR1, NPRA;atrionatriuretic peptide receptor A, NR4A1, NR4A3, NRCAM, NRDE2, NRXN1, NRXN3, NSD1, NSD3, NTRK2, NTRKR3;discoidin domain receptor family, NUDT1, NUF2, NUMBL, NUPR1, Norrie disease (pseudoglioma), Notch (Drosophila) homolog 2, Notch homolog 1, Notch homolog 2 (Drosophila), Notch homolog 3 (Drosophila), OAS3, OAZ1, OB;leptin (murine obesity homolog), OBS, OCLN, OGN, OLFML2B, OPN;osteopontin, ORC6, ORC6L;origin recognition complex, ORW2;activin A receptor type II-like 1, OSRC;osteosarcoma, Oaz, P-cadherin (placental), P0, PALB2, PALMD, PARP1, PARP2, PARP4, PAX5, PAX8, PBT;piebald trait, PBX3, PCAF;p300/CBP-associated factor, PCHC1;keratin 17, PCK1, PCNA, PDCD1LG1;programmed cell death 1 ligand 1, PDCD1LG2, PDE9A, PDGFB, PDGFR;platelet-derived growth factor receptor, PDGFRA, PDGFRB, PDK4, PDNP2, PECAM1, PFD;D component of complement (adipsin), PFDN2, PGK1, PGR, PHGDH, PHS;Greig cephalopolysyndactyly syndrome, PI, PI5;serine (or cysteine) proteinase inhibitor, PIK3CA, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, PIM1, PIM;pim-1 oncogene, PIP, PKCA;protein kinase C, PKCB, PKMYT1, PLA1A, PLA2B, PLA2G2A, PLA2G3, PLA2G4;phospholipase A2, PLA2G4A, PLA2G4F, PLA2L;phospholipase A2, PLAT, PLCB1, PLCB4, PLCE1, PLD1, PLML;FXYD domain-containing ion transport regulator 3, POLD1, POLD;polymerase (DNA directed), POLQ, POLR2;polymerase (RNA) II (DNA directed) polypeptide A, POLR2A, POPDC3, PPARBP;PPAR binding protein, PPARG, PPARGBP, PPARGC1;peroxisome proliferative activated receptor, PPARGC1A, PPCD3;transcription factor 8 (represses interleukin 2 expression), PPH1;primary pulmonary hypertension 1, PPOL, PPP2CB, PPP2R1A, PPP2R2C, PRAD1;cyclin D1 (PRAD1: parathyroid adenomatosis 1), PRC1, PREP, PRF1, PRKAA2, PRKAA;protein kinase, PRKACA, PRKACB, PRKCA, PRKCB, PRKCB1;protein kinase C, PRKCB2, PRKDC, PRKM1, PRKM10, PRKM2, PRKM3, PRKM8IPL;PRKM8 interacting protein-like, PRKX, PRLR, PROM1, PROML1, PSACH, PSAT1, PSMB10, PSMB7, PSMB9, PSMC4, PSOR1;S100 calcium-binding protein A7 (psoriasin 1), PSORS1;psoriasis susceptibility 1, PTCH1, PTCH;patched (Drosophila) homolog, PTEN, PTGDS, PTGER3, PTGS2, PTTG1, PUM, PUM1, PUMB1, PYCARD, RAC2, RAC3, RAD51, RAD51 (S. cerevisiae) homolog C, RAD51 homolog (RecA homolog, RAD51 homolog (S. cerevisiae), RAD51 homolog C (S. cerevisiae), RAD51A, RAD51C, RAD52, RAD52 (S. cerevisiae) homolog, RAD52 homolog (S. cerevisiae), RAD53;CHK2 (checkpoint, RAD54 (S.cerevisiae)-like, RAD54 like (S. cerevisiae), RAD54L, RAR-related orphan receptor A, RAR-related orphan receptor B, RARRES3, RAS guanyl releasing protein 1 (calcium and DAG-regulated), RAS protein activator like 1 (GAP1 like), RASAL1, RASGRF1, RASGRF2, RASGRP1, RB1, RBBP3, RBL1, RBL2, RBX1, RECA;RAD51 (S. cerevisiae) homolog (E coli RecA homolog), RELN, RFC4, RNASE2, RNF103, RNS2;ribonuclease, RNase A family, ROBO4, ROCK1, ROCK2, RORA, RORB, RPD3L1, RPLP0, RPS6KA5, RPS6KB1, RPS6KB2, RRM2, RSTS;Rubinstein-Taybi syndrome, RUNX3, S-phase kinase-associated protein 2, S-phase kinase-associated protein 2 (p45), S. cerevisiae, S. cerevisiae) homolog, S. cerevisiae) homolog B, S.pombe) homolog, S100 calcium binding protein A7 (psoriasin 1), S100A14, S100A7, S1PR1, SAM pointed domain containing ets transcription factor, SBMA;dihydrotestosterone receptor, SCA15, SCA16, SCA17, SCA29;spinocerebellar ataxia 15, SCARA5, SCUBE2, SCYA21;small inducible cytokine subfamily A (Cys-Cys), SCYA2;small inducible cytokine A2 (monocyte chemotactic protein 1, SCYA3L, SCYA3L1;small inducible cytokine A3-like 1, SCYA4;small inducible cytokine A4 (homologous to mouse Mip-1b), SCYA5;small inducible cytokine A5 (RANTES), SCYA6, SCYA7;small inducible cytokine A7 (monocyte chemotactic protein 3), SCYA8;small inducible cytokine subfamily A (Cys-Cys), SCYAR1, SCYB10;small inducible cytokine subfamily B (Cys-X-Cys), SCYB13;small inducible cytokine B subfamily (Cys-X-Cys motif), SCYB5;small inducible cytokine subfamily B (Cys-X-Cys), SDF1;stromal cell-derived factor 1, SDF1A, SDF1B, SDGF, SDH2;succinate dehydrogenase complex, SDHA, SEDC, SELE, SERBP1, SERK1, SERPINA8;serpin peptidase inhibitor, SERPINB5, SERPINH1, SERPINH2;serine (or cysteine) proteinase inhibitor, SF3A1, SFN, SFRP1, SFRP2, SFRP4, SHC (Src homology 2 domain containing) family, SHC (Src homology 2 domain containing) transforming protein 2, SHC2, SHC4, SHE, SHMT2, SHMT;serine hydroxymethyltransferase 2 (mitochondrial), SIAT7, SIAT7B, SIATL1;sialyltransferase 7 ((alpha-N-acetylneuraminyl-2, SID1 transmembrane family, SIDT1, SIGIRR, SIS;platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog), SIX1, SKA3, SKP1, SKP1A;S-phase kinase-associated protein 1A (p19A), SKP2, SLC2A1, SLC39A6, SLC44A4, SLPI, SLUG;slug homolog, SMAD, SMAD1, SMAD3, SMAD4, SMAD5, SMARCF1;SWI/SNF related, SMC1 structural maintenance of chromosomes 1-like 2 (yeast), SMC1B, SMC1L2;SMC1 (structural maintenance of chromosomes 1, SMO, SMOH;smoothened (Drosophila) homolog, SMURF2, SNAI1, SNAI2, SOCS1, SOCS2, SOCS3, SOX10, SOX17, SOX2, SOX9, SP1, SPBC25;spindle pole body component 25 homolog (S. cerevisiae), SPC25, SPDEF, SPN, SPP1, SPRY1, SPRY2, SPRY4, SRPX, SRY (sex determining region Y)-box 10, SRY (sex determining region Y)-box 17, SRY (sex determining region Y)-box 2, SRY (sex determining region Y)-box 9, SRY box 10, SRY box 17, SRY box 2, SRY box 9, ST16, ST6 (alpha-N-acetyl-neuraminyl-2, ST6 GalNAc alpha-2, ST6GALNAC2, STAT1, STC, STC1, STGD4;prominin (mouse)-like 1, STK11IP, STK12;serine/threonine kinase 12, STK14A;ribosomal protein S6 kinase, STK15, STK6;serine/threonine kinase 15, STMY1, STMY3;matrix metalloproteinase 11 (stromelysin 3), STMY;matrix metalloproteinase 3 (stromelysin 1, STO;Sotos syndrome, SUR4/Elo3, SUV39H2, SYTL4, Shab-related subfamily, Stargardt disease 4 (autosomal dominant), T cell immunoreceptor with Ig and ITIM domains, T type, T-cell leukemia, T-cell surface glycoprotein CD8 alpha chain, TAN1;Notch (Drosophila) homolog 1 (translocation-associated), TAP binding protein (tapasin), TAP1, TAP2, TAPBP, TBC1 domain family, TBC1D10B, TBC1D9, TBP, TBX1, TCEAL1, TCF1;transcription factor 1, TCF3;transcription factor 7-like 1 (T-cell specific, TCF4, TCF7L1, TCF8, TCL3, TEK, TEK tyrosine kinase, TFDP1, TFF1, TFF3, TFRC, TGFB, TGFB1, TGFB2, TGFB3, TGFB4, TGFBR2, THBS1, THBS2, THBS4, THY1, TIE1, TIE;tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 1, TIGIT, TIMP4, TLE3, TLR4, TLX1, TM4SF2, TMEM3, TMEM45B, TMPRSS2, TMPRSS4, TNF, TNFA;tumor necrosis factor (TNF superfamily, TNFAIP6, TNFC, TNFRSF7;tumor necrosis factor receptor superfamily, TNFSF10, TNKS, TNKS2, TNN, TOP2;topoisomerase (DNA) II alpha 170kDa, TP53, TPS1, TPS2;tryptase beta 1, TPSAB1, TPSB1, TRF1-interacting ankyrin-related ADP-ribose polymerase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2, TRIP13, TRIP2, TS, TSPAN1, TSPAN7, TTK, TTYH1, TUBA1;tubulin, TUBA4A, TUTR1, TWIST, TWIST1, TWIST2, TYK2, TYMP, TYMS, TYRO10, Top2a, UBB, UBE2C, UBE2T, UVO;cadherin 1, V-set and transmembrane domain containing 3, VCAN, VCF;velocardiofacial syndrome, VE-cadherin (vascular epithelium), VEGF;vascular endothelial growth factor, VEGFA, VEGFD, VGR;vegetal related growth factor (TGFB-related), VIM, VIT, VMCM;venous malformations, VNRA, VSIG9, VSTM3;V-set and immunoglobulin domain containing 9, VTNR;antigen identified by monoclonal antibody L230, VWS, WDR77, WDTC2;WD and tetratricopeptide repeats 2, WEE1, WEE1 homolog (S. pombe), WHSC1L1;Wolf-Hirschhorn syndrome candidate 1-like 1, WIF1, WMS;fibrillin 1 (Marfan syndrome), WNT10A, WNT11, WNT2, WNT4, WNT5A, WNT5B, WNT6, WNT7B, WRN, WT1, Werner syndrome, X chromosome, X-linked, X-linked 58, X-ray repair complementing defective repair in Chinese hamster cells 2, X-ray repair complementing defective repair in Chinese hamster cells 3, XRCC2, XRCC3, ZBTB16, ZEB1, ZEB2, ZFHX1B;zinc finger homeobox 1b, ZFP103;zinc finger protein 103 homolog (mouse), ZFPM2, ZFYVE9, ZIC2, ZNF145;zinc finger protein 145 (Kruppel-like, ZNF205, ZNF210, ZNF62;zinc finger protein 62, ZNFN1A3;zinc finger protein, ZPK, Zic family member 2 (odd-paired Drosophila homolog), Zic family member 2 (odd-paired homolog, a disintegrin and metalloproteinase domain 12 (meltrin alpha), acrocephalosyndactyly 3, actin binding protein, actin binding protein (scraps homolog, actin dependent regulator of chromatin, activin A receptor, activin A receptor type IL, activin AB alpha polypeptide), adducin 1 (alpha), albumin proximal factor, aldolase A, alpha, alpha (1, alpha (low affinity), alpha 1 (primary osteoarthritis, alpha 1 (testis specific), alpha 1D subunit, alpha 1H subunit, alpha 2, alpha 2 catalytic subunit, alpha 2/delta subunit 1, alpha 2/delta subunit 3, alpha 3, alpha 3 (nicein (150kD), alpha 5 (neuronal), alpha 6, alpha B, alpha V, alpha V (vitronectin receptor, alpha catalytic subunit, alpha isoform, alpha polypeptide, alpha polypeptide (p32), alpha polypeptide 5, alpha subunit (basic helix-loop-helix transcription factor), alpha-induced protein 6, alpha-inducible protein (clone IFI-15K), amphiregulin B, angiogenesis inhibitor, anillin (Drosophila Scraps homolog), antagonist of FGF signaling (Drosophila), anterior gradient 2 homolog (Xenopus laevis), anterior pharynx defective 1 homolog B (C. elegans), antigen CD29 includes MDF2, antigen CD51), antigen CD61), antigen identified by monoclonal antibody Ki-67, arthroophthalmopathy, asp (abnormal spindle) homolog, asp (abnormal spindle)-like, asporin (LRR class 1), ataxia telangiectasia mutated, autosomal dominant 23, autosomal recessive 39, autosomal sex-reversal, axon guidance receptor, baculoviral IAP repeat-containing 5, beta, beta 1, beta 1 (fibronectin receptor, beta 1 (phosphoinositide-specific), beta 2, beta 3, beta 3 (nicein (125kD), beta 3 (platelet glycoprotein IIIa, beta 6, beta A, beta A (activin A, beta B, beta B (activin AB beta polypeptide), beta catalytic subunit, beta isoform, beta isozyme, beta polypeptide, beta polypeptide 1 (p37), beta receptor II (70/80kDa), beta type, beta-4, bone morphogenetic protein receptor, bone morphogenetic protein receptor type II, bone sialoprotein I, brain], breast cancer 1, breast cancer 2, cAMP-dependent, cadherin 3, cadherin 5, calcineurin-dependent 1, calcium channel, calcium-dependent), calmodulin-like 5, carbohydrate recognition domain) lectin, carbonic anhydrase XII, carboxypeptidase A3 (mast cell), catalytic, catalytic subunit, catalytic subunit (125kD), catalytic subunit alpha, catalytic subunit delta, catalytic subunit gamma, cathepsin W (lymphopain), caveolae protein, caveolin-1, cell division cycle 20 homolog (S. cerevisiae), cell division cycle 25 homolog A (S. cerevisiae), cell division cycle 25 homolog A (S. pombe), cell division cycle 25 homolog B (S. cerevisiae), cell division cycle 25 homolog B (S. pombe), cell division cycle 25 homolog C (S. cerevisiae), cell division cycle 25 homolog C (S. pombe), cell division cycle 25A, cell division cycle 25B, cell division cycle 6 homolog (S. cerevisiae), cell division cycle 7 (S. cerevisiae), cell division cycle 7 homolog (S. cerevisiae), cell division cycle associated 7-like, centromere protein F, centrosomal protein 55kDa, chemokine (C-C motif) ligand 2, chemokine (C-C motif) ligand 21, chemokine (C-C motif) ligand 3-like 1, chemokine (C-C motif) ligand 4, chemokine (C-C motif) ligand 5, chemokine (C-C motif) ligand 7, chemokine (C-C motif) ligand 8, chemokine (C-C motif) receptor 5 (gene/pseudogene), chemokine (C-X-C motif) ligand 10, chemokine (C-X-C motif) ligand 12, chemokine (C-X-C motif) ligand 13, chemokine (C-X-C motif) ligand 5, chemokine (C-X-C motif) ligand 8, chemokine (C-X-C motif) ligand 9, chemokine (C-X-C motif) receptor 6, chemokine-like receptor 1, chitinase 1 (chitotriosidase), chitinase 3-like 1 (cartilage glycoprotein-39), cholinergic receptor, choreoathetosis/spasticity, chromosome 21 open reading frame 45, clade A, clade B (ovalbumin), clade H (heat shock protein 47), coactivator 1, coactivator 1 alpha, coagulation factor III (thromboplastin, collagen, collagen type II alpha 1, collagen type XXVII alpha 1, colon cancer, colorectal adenoma and carcinoma 1, complement factor D (adipsin), complementation group D1, congenital), coxsackie virus and adenovirus receptor, craniofacial dysostosis 1, craniosynostosis, cyclin-dependent kinase inhibitor 1B (p27, cyclin-dependent kinase inhibitor 1C (P57), cyclin-dependent kinase inhibitor 2B (p15, cyclin-dependent kinase inhibitor 2C (p18, cyclin-dependent kinase inhibitor 2D (p19, cysteine knot superfamily, cytochrome P450, cytochrome b-245, cytoplasmic, cytotoxic T-lymphocyte-associated serine esterase 1), cytotoxic T-lymphocyte-associated serine esterase 3), damage-specific DNA binding protein 2 (48kD), deafness, dehydrogenase/reductase (SDR family) member 2, delta (Drosophila)-like 1, delta (Drosophila)-like 3, delta 1, delta polypeptide, delta-like 1 (Drosophila), delta-like 3 (Drosophila), delta-like 4 (Drosophila), delta-like 4 homolog (Drosophila), deltex 3 homolog (Drosophila), deltex homolog 1 (Drosophila), deltex homolog 3 (Drosophila), deltex homolog 4 (Drosophila), dickkopf (Xenopus laevis) homolog 1, dickkopf (Xenopus laevis) homolog 2, dickkopf 1 homolog (Xenopus laevis), dickkopf 2 homolog (Xenopus laevis), discs, discs large homolog associated protein 5, dominant and recessive, dominant negative helix-loop-helix protein, double strand break repair nuclease, dystrophic, e polypeptide, early onset, egl nine homolog 2 (C. elegans), egl nine homolog 3 (C. elegans), elongation of very long chain fatty acids (FEN1/Elo2, endothelial, enteropathy, eosinophil-derived neurotoxin), epicanthus inversus and ptosis 3, epidermal growth factor (beta-urogastrone), epilegrin), epiphyseal dysplasia 1, episodic (paroxysmal choreoathetosis/spasticity), epithelial-specific ), epsilon 1, estrogen-inducible sequence expressed in, ets variant gene 4 (E1A enhancer-binding protein, ets variant gene 7 (TEL2 oncogene), eukaryotic translation initiation factor 3, expressed in promyelocytic leukemia), extra spindle pole bodies homolog 1 (S. cerevisiae), extra spindle poles like 1 (S. cerevisiae), extracellular matrix protein 2, eyes absent (Drosophila) homolog 2, eyes absent homolog 1 (Drosophila), eyes absent homolog 2 (Drosophila), eyes absent homolog 4 (Drosophila), factor A; transforming growth factor beta superfamily), family 4, family with sequence similarity 124B, family with sequence similarity 198, family with sequence similarity 214, family with sequence similarity 83, female organ and adipocyte specific, fibrinogen-like 2, fibroblast activation protein, fibroblast growth factor 7 (keratinocyte growth factor), fibroblast growth factor 9 (glia-activating factor), filamin C, flavoprotein (Fp), fms-related tyrosine kinase 3, follistatin-like 1, follistatin-like 3 (secreted glycoprotein), frizzled (Drosophila) homolog 10, frizzled (Drosophila) homolog 7, frizzled (Drosophila) homolog 8, frizzled (Drosophila) homolog 9, frizzled 10, frizzled 7, frizzled 8, frizzled 9, frizzled family receptor, frizzled family receptor 10, frizzled family receptor 7, frizzled family receptor 8, frizzled family receptor 9, frizzled homolog 10 (Drosophila), frizzled homolog 7 (Drosophila), frizzled homolog 8 (Drosophila), frizzled homolog 9 (Drosophila), fructose-bisphosphate, gamma, gamma (actin binding protein 280), gamma 2 (nicein (100kD), gamma 4, gamma isoform, gamma polypeptide, gamma subunit 1, gamma subunit 4, gamma subunit 6, gamma-aminobutyric acid (GABA) A receptor, gap junction protein, general transcription factor IIH, glioma-associated oncogene family zinc finger 3, glucuronidase, glutamate receptor, glutathione peroxidase 3 (plasma), granzyme M (lymphocyte met-ase 1), gremlin 1, group A, group IIA (platelets, group III, group IVA (cytosolic, group IVF, growth arrest and DNA-damage-inducible, growth factor receptor-bound protein 2, growth factor receptor-bound protein 7, guanine nucleotide binding protein (G protein), hairy and enhancer of split 1, heart development protein with EGF-like domains 1, heat shock 70kD protein 2, heat shock 70kDa protein 2, hemoglobin, hepatic nuclear factor (HNF1), hepatic; LF-B1, hepatocyte growth factor (hepapoietin A; scatter factor), high affinity I, histone 1, histone 3, histone cluster 1, histone cluster 3, homeo box B13, homeobox 1, homolog (S. cerevisiae), homolog (Xenopus laevis), homolog 4 (Drosophila), homolog), homolog)-like 1, homologous to mouse Sig-je), human homolog of; p53-binding protein, hypoxia inducible factor 1, inhibin, inhibin beta A, inhibitor of DNA binding 1, inhibitor of DNA binding 2, inhibitor of DNA binding 4, inhibitor of differentiation 2, inhibits CDK4), inositol 1, insulin-like growth factor 1 (somatomedin C), insulin-like growth factor 1 receptor, integrin, interleukin 11 receptor, interleukin 12 receptor, interleukin 13 receptor, interleukin 2 receptor, interleukin 20 receptor, interleukin 20 receptor alpha subunit, interleukin 20 receptor beta, interleukin 20 receptor beta subunit, interleukin 22 receptor, interleukin 3 receptor, intraflagellar transport 140 homolog (Chlamydomonas), ionotrophic, ionotropic, isoenzyme 4, isozyme 4, isthmin 1, isthmin 1 homolog (zebrafish), jun oncogene, kalinin (105kD), kalinin (140kD), kalinin (165kD), keratin 14, keratin 5, keratin 5 (epidermolysis bullosa simplex, keratin 6B, keratin 7, keratinocyte growth factor receptor, killer cell lectin-like receptor subfamily K, kinase insert domain receptor (a type III receptor tyrosine kinase), kinetochore associated 2, laminin, large, large (Drosophila) homolog-associated protein 5, large homolog 7 (Drosophila), large multifunctional peptidase 2, late onset), leptin (obesity homolog, leukemia inhibitory factor, leukemia inhibitory factor receptor, leukemia inhibitory factor receptor alpha, leukosialin, low density lipoprotein receptor-related protein 2, lunatic fringe (Drosophila) homolog, lunatic fringe homolog (Drosophila), lymphocyte-activation gene 3, lymphoid enhancer-binding factor 1, macropain) 26S subunit, macropain) subunit, macular dystrophy, manic fringe (Drosophila) homolog, manic fringe homolog (Drosophila), mastermind (Drosophila)-like 2, mastermind-like 2 (Drosophila), matrix associated, matrix metallopeptidase 14 (membrane-inserted), matrix metalloproteinase 14 (membrane-inserted), mechanistic target of rapamycin, mechanistic target of rapamycin (serine/threonine kinase), medullary cystic kidney disease 1 (autosomal dominant), member 0, member 1, member 10, member 10A, member 10B, member 11, member 12, member 13 (B-cell chemoattractant), member 15, member 16), member 2, member 2 (Fc fragment of IgE, member 21, member 3, member 4, member 5, member 5 (epithelial-derived neutrophil-activating peptide 78), member 5 (putative), member 5A, member 5B, member 6, member 7, member 7B, member 8, member 8 (monocyte chemotactic protein 2), member 9 (with GRAM domain), member A, member A1, member B, member B (zinc finger protein), member D, member J, member K, membrane-spanning 4-domains, mental retardation, mesenchyme forkhead 1), mesenchyme homeobox 2 (growth arrest-specific homeo box), met proto-oncogene, microcephaly associated (Drosophila), minichromosome maintenance deficient (S. cerevisiae) 3, mitochondrial 1 (ubiquitous), mitotin (S. cerevisiae), mothers against DPP homolog 1 (Drosophila), mothers against DPP homolog 3 (Drosophila), mothers against DPP homolog 4 (Drosophila), mothers against DPP homolog 5 (Drosophila), mothers against decapentaplegic homolog (Drosophila) interacting protein, mothers against decapentaplegic homolog 1 (Drosophila), mothers against decapentaplegic homolog 3 (Drosophila), mothers against decapentaplegic homolog 4 (Drosophila), mothers against decapentaplegic homolog 5 (Drosophila), mouse double minute 2, mouse), multiple cutaneous and mucosal, multiple), multitype 2, mutL homolog 1, myeloid/lymphoid or mixed-lineage leukemia; translocated to, natriuretic peptide receptor A, natural killer cell group 7 sequence, nei endonuclease VIII-like 1 (E. coli), nei endonuclease VIII-like 3 (E. coli), neogenin (chicken) homolog 1, nerve growth factor receptor (TNFR superfamily, neuropilin (NRP) and tolloid (TLL)-like 2, neurotrophic tyrosine kinase, nicotinic, nicotinic alpha 5, non-SMC condensin II complex, nonpolyposis type 2, nonpolyposis type 2 (E. coli), nuclear autoantigenic sperm protein (histone-binding), nuclear factor of activated T-cells, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, nuclear receptor subfamily 4, numb (Drosophila) homolog-like, olfactomedin-like 2B, origin recognition complex, osteoglycin (osteoinductive factor), p130-binding, p16, p53 binding protein (mouse), paired box gene 5 (B-cell lineage specific activator protein), paired box gene 5 (B-cell lineage specific activator), paired box gene 8, patched homolog (Drosophila), patched homolog 1 (Drosophila), perforin 1 (pore forming protein), peroxisome proliferative activated receptor, peroxisome proliferator-activated receptor gamma, phosphatidylcholine-specific, phosphatidylinositol-4, phosphoenolpyruvate carboxykinase 1 (soluble), phosphoinositide-3-kinase, phospholipase A2, phospholipase C, phospholipase D1, plasminogen activator, platelet-derived growth factor beta polypeptide, platelet-derived growth factor receptor, platelet/endothelial cell adhesion molecule 1, poly (ADP-ribose) polymerase family, polyendocrinopathy, polymerase (DNA directed), polymerase (DNA) delta 1, polymerase (DNA) theta, polypeptide 1, polypeptide 2, polypeptide 2 (44kD subunit), polypeptide 3, polypeptide 3 (leukotriene B4 omega hydroxylase), polypeptide 5, posterior polymorphous corneal dystrophy 3, potassium voltage-gated channel, pre-B-cell leukemia homeobox 3, pre-B-cell leukemia transcription factor 3, prefoldin 2, primary autosomal recessive 5, progelatinase, progressive (Stickler syndrome), prolactin-induced protein, properdin factor D, prostaglandin D2 synthase (21kD, prostaglandin D2 synthase 21kDa (brain), prostaglandin E receptor 3 (subtype EP3), prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), proteasome (prosome, protein h-CCPX), protein kinase, protein kinase C, protein phosphatase 2, protein phosphatase 2 (formerly 2A), pumilio homolog 1 (Drosophila), pyruvate dehydrogenase kinase, ras-related C3 botulinum toxin substrate 2 (rho family, ras-related C3 botulinum toxin substrate 3 (rho family, receptor, receptor activation anchor, receptor for; beta polypeptide), regulatory subunit 1 (alpha), regulatory subunit 2 (beta), regulatory subunit 3 (gamma), regulatory subunit 5, regulatory subunit A (PR 65), regulatory subunit B (PR 52), replication factor C (activator 1) 4, replication factor C (activator 1) 4 (37kD), retinal 2, retinoblastoma 1, retinoblastoma-like 1, retinoblastoma-like 2, retinoic acid receptor responder (tazarotene induced) 3, ribonucleotide reductase M2 polypeptide, ribosomal protein, ribosomal protein S6 kinase, rich in leucine heptad repeats (yeast), ring-box 1, roundabout, roundabout homolog 4 (Drosophila), scavenger receptor class A, secreted frizzled-related protein 4, secretory leukocyte protease inhibitor (antileukoproteinase), serine (or cysteine) proteinase inhibitor, serine/threonine kinase 6, serpin peptidase inhibitor, seven transmembrane spanning receptor, sialophorin (gpL115, sialyltransferase-like 1, signal peptide, signal transducer and activator of transcription 1, sine oculis homeobox homolog 1 (Drosophila), single immunoglobulin and toll-interleukin 1 receptor (TIR) domain, small GTP binding protein Rac2), small GTP binding protein Rac3), smoothened, smoothened homolog (Drosophila), snail 1 (drosophila homolog), snail family zinc finger 1, snail family zinc finger 2, snail homolog 1 (Drosophila), snail homolog 2 (Drosophila), solute carrier family 2 (facilitated glucose transporter), solute carrier family 39 (metal ion transporter), solute carrier family 39 (zinc transporter), solute carrier family 44, sphingolipid G-protein-coupled receptor, spinal and bulbar muscular atrophy, spinocerebellar ataxia 16, spinocerebellar ataxia 29, splicing factor 3a, spondyloepiphyseal dysplasia, sprouty (Drosophila) homolog 1 (antagonist of FGF signaling), sprouty (Drosophila) homolog 2, sprouty homolog 1, sprouty homolog 2 (Drosophila), sprouty homolog 4 (Drosophila), stromelysin 3, stromelysin-1, sub-family A (ABC1), sub-family B (MDR/TAP), sub-family F (GCN20), subfamily 1A, subfamily A, subfamily C, subfamily IVF, subfamily f, subunit 1, subunit 6, subunit 6 homolog-like (yeast), subunit 6 like (yeast), subunit 9 eta, subunit A, subunit B, subunit H2, succinate dehydrogenase complex subunit A, superfamily member 5, suppressor of variegation 3-9 homolog 2 (Drosophila), sushi-repeat-containing protein, synovial fluid), tankyrase, thanatophoric dwarfism, theta, thrombospondin receptor), tissue, tissue factor, tissue inhibitor of metalloproteinase 4, toll-like receptor 4, transcription elongation factor A (SII)-like 1, transducin-like enhancer of split 3 (E(sp1) homolog, transferrin receptor (p90, transformed 3T3 cell double minute 2, transforming growth factor, transforming growth factor beta receptor II, translocation-associated (Drosophila), transmembrane, trefoil factor 3 (intestinal), tubulin, tumor necrosis factor, tumor necrosis factor (ligand) superfamily, tweety (Drosophila) homolog 1, tweety homolog 1 (Drosophila), twist basic helix-loop-helix transcription factor 1, twist basic helix-loop-helix transcription factor 2, twist homolog 1 (Drosophila), twist homolog 2 (Drosophila), type 1, type 10B, type 2, type 2 (vascular endothelium), type I, type IA, type IB, type IC, type II, type II (serine/threonine kinase), type IV, type IX, type VI, type VII, type XI, type XXVII, tyrosine kinase with immunoglobulin-like and EGF-like domains 1, ubiquitin-conjugating enzyme E2C, ubiquitin-conjugating enzyme E2T, uterine), v-akt murine thymoma viral oncogene homolog 3, v-erb-a avian erythroblastic leukemia viral oncogene homolog-like 4, v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2, v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4, v-fos FBJ murine osteosarcoma viral oncogene homolog, v-jun avian sarcoma virus 17 oncogene homolog, v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog, v-myb avian myeloblastosis viral oncogene homolog-like 2, v-myc avian myelocytomatosis viral oncogene homolog, vitronectin receptor, voltage-dependent, wee1+ (S. pombe) homolog, wingless-type MMTV integration site family, yeast, yeast)-like 1, yeast)-like 2, zeta, zinc finger, zinc finger protein, zinc finger protein (chicken)
